Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 3,953–3,960 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Syndax Pharmaceuticals Inc. Niktimvo (axatilimab-csfr) - (MAXPIRe) Idiopathic pulmonary fibrosis (IPF) Phase 2 Ongoing Intravenous Respiratory
Syndax Pharmaceuticals Inc. Revumenib with venetoclax and decitabine/cedazuridine - (SAVE) R/R or newly diagnosed AML Phase 2 Data Released Oral Oncology
Syndax Pharmaceuticals Inc. Entinostat plus TECENTRIQ (atezolizumab) - (ENCORE 602) Triple negative breast cancer (TNBC) Phase 2 Trial Discontinued Intravenous Oncology
Synlogic Inc. labafenogene marselecobac (SYNB1934) - (Synpheny-3) Phenylketonuria (PKU) Phase 3 Trial Discontinued oral Genetic Disorder
Synlogic Inc. labafenogene marselecobac (SYNB1934) - (Synpheny-3) Phenylketonuria (PKU) Phase 3 Trial Discontinued oral Genetic Disorder
Synlogic Inc. labafenogene marselecobac (SYNB1934) - (Synpheny-3) Phenylketonuria (PKU) Phase 3 Trial Discontinued oral Genetic Disorder
Synlogic Inc. labafenogene marselecobac (SYNB1934) - (Synpheny-3) Phenylketonuria (PKU) Phase 3 Trial Discontinued oral Genetic Disorder
Synlogic Inc. SYNB1618 - (SynPheny-1) Phenylketonuria (PKU) Phase 2 Trial Planned oral Genetic Disorder